Revealed preferences towards the appraisal of orphan drugs in Poland - multi criteria decision analysis.

Katarzyna KolasaKrzysztof Miroslaw ZwolinskiVladimir ZahZoltán KalóTadeusz Lewandowski

Published in: Orphanet journal of rare diseases (2018)

MCDA can be regarded as a valuable tool for revealing decision makers' preferences in the healthcare sector. Given that only roughly half of all criteria included in the MCDA matrix were deemed to make an impact on the HTA process, there is certainly some room for improvement with respect to the adaptation of a new approach towards the value assessment of OMPs in Poland.

Keyphrases

decision making
healthcare
single cell
health information
data analysis
clinical evaluation